Search

Displaying results 5621 - 5630 of 8010 in total
  1. Drug

    Vonapanitase

    go.drugbank.com/drugs/DB11690
    Investigational

    Vonapanitase is under investigation for the treatment of Chronic Kidney Disease.

  2. Drug

    Tegobuvir

    go.drugbank.com/drugs/DB11852
    Investigational

    Tegobuvir has been investigated for the treatment of Hepatitis C, Chronic.

  3. Drug

    Pilsicainide

    go.drugbank.com/drugs/DB12712
    Investigational

    Pilsicainide has been investigated for the treatment of Paroxysmal Atrial Fibrillation.

  4. Drug

    Olitigaltin

    go.drugbank.com/drugs/DB12895
    Investigational

    Olitigaltin has been investigated for the treatment of Idiopathic Pulmonary Fibrosis.

  5. Drug

    Tropatepine

    go.drugbank.com/drugs/DB13252
    Experimental

    Tropatepine has been used in France for its antiparkinsons activities [A175024].

  6. Drug

    Vedroprevir

    go.drugbank.com/drugs/DB12037
    Investigational

    Vedroprevir has been investigated for the treatment of Hepatitis C, Chronic.

  7. Drug

    Tavilermide

    go.drugbank.com/drugs/DB12441
    Investigational

    Tavilermide has been investigated for the treatment of Dry Eye Syndromes.

  8. Drug

    Fosbretabulin

    go.drugbank.com/drugs/DB12577
    Investigational

    Fosbretabulin has been investigated for the treatment of Anaplastic Thyroid Cancer.

  9. Drug

    Riferminogene pecaplasmid

    go.drugbank.com/drugs/DB06394
    Investigational

    Riferminogene pecaplasmid (non-viral fibroblast growth factor 1; NV1FGF) is a recombinant DNA plasmid in a pCOR backbone allowing expression of human FGF1.

  10. Drug

    LY-2599506

    go.drugbank.com/drugs/DB05970
    Investigational

    LY2599506 was under investigation in clinical trials NCT01024244 and NCT01029795 for the treatment of patients with type 2 diabetes.